Jeffrey B. Landau, CFO: CytomX Therapeutics CTMX Sell · Filed 23/03/20

Trade details

Type: Insider sale
Amount: $2,924.46
Shares · price: 1,477 sh · $1.98 a share
Held after: 69,248 sh
Stock: CytomX Therapeutics CTMX
Person: Jeffrey B. LandauCFO
Trade date: 23/03/16
Filed: 23/03/20
Days to filing: 4 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

CytomX Therapeutics trades, last 26 weeks

What else happened in CytomX Therapeutics around then

Filed or reported within 30 days of the trade day · 23/02/14~23/04/15

Jeffrey B. Landau's recent trades

Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,143
4,181 sh
$5,143
Filed 24/08/22
Traded 24/08/20
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$13.7K
6,562 sh
$13.7K
Filed 24/03/21
Traded 24/03/19
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,626
4,077 sh
$5,626
Filed 23/12/22
Traded 23/12/20
Jeffrey B. LandauChief Business Officer
SellCytomX Therapeutics
Sell
CytomX Therapeutics
CTMX
$5,355
4,119 sh
$5,355
Filed 23/09/22
Traded 23/09/22

Jeffrey B. Landau, CFO — sold $2,924 of CytomX Therapeutics CTMX · 2.1% of holdings | Whalegun